What is Deep Brain Stimulation for depression? Discover how the TRANSCEND trial at UT Southwestern is using "brain pacemakers" to treat treatment-resistant depression by targeting neural communication ...

Alto Neuroscience secures $120M to advance novel depression therapy ALTO-207 through Phase 3 trials, aiming for FDA ...

Is paternal postnatal depression delayed? New research finds a 30% increase in depression and stress diagnoses for fathers ...

Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today reported ...

People with depression tend to prefer carbohydrate-rich foods, according to a new study published in Psychological Medicine. The findings point toward the possibility of dietary therapies for ...

On Tuesday, Alto Neuroscience, Inc. (NASDAQ:ANRO) announced an asset purchase agreement with Chase Therapeutics Corporation for a portfolio of dopamine agonist drug combinations for ...

Alto Neuroscience (ANRO) has announced a private placement financing (PIPE) agreement to raise approximately $120 million before expenses. The financing is led by Commodore Capital with support from ...

Young women with depression are more likely to have lower levels of taurine in their hippocampus than healthy controls. The corresponding study was published in Biological Psychiatry. Between 2013 and ...

Neuropsychiatric drug development is rife with clinical trial failures, but Alto Neuroscience aims to overcome these hurdles with a precision medicine approach that matches a patient to a drug. A ...

In January, Reunion completed its Phase 1 placebo-controlled study. Reunion’s other pipeline program is the RE200 series, which are novel molecules structurally similar to classic psychedelics. Get ...

NYSE-listed Alto Neuroscience has raised $120 million in a private placement that will be used to advance its recently ...

Explore neuroscience breakthroughs reshaping treatments for Alzheimer’s, Parkinson’s, PTSD, and other brain disorders.